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Although progress has been made towards international goals for the eradication of hunger and malnutrition, considerable work is still required to
achieve them and to respond to emerging public health nutrition challenges. The present paper outlines sixteen major inter-linked nutrition chal-
lenges recently identified by the UN Standing Committee on Nutrition. While many of the challenges relate to the nutritional needs of children and
mothers, an increased emphasis on nutrition-related chronic diseases that affect later life is also evident. Promoting healthy ageing and the main-
tenance of physical and mental function in older age are undoubtedly major challenges for the future, and the present paper also informs on the role
of nutrition, specifically n-3 essential fatty acids, in the prevention of cognitive decline. The importance of determining the cost-effectiveness of
nutrition interventions is advocated, in order that the nutrition community can respond appropriately to global nutrition challenges.
Healthy nutrition: Nutrition challenges: Malnutrition: Ageing: Cognition
Goals set in decades prior to the end of the twentieth century
to mark the progress in advancing the war on hunger and mal-
nutrition have been partially achieved. These goals were
established in the UNICEF World Summit for Children in
1990, the International Conference on Nutrition (Food and
Agriculture Organization/World Health Organization, 1992),
and the FAO World Food Summit in 1996. Hunger and mal-
nutrition eradication goals were part of a broader strategy to
eliminate poverty as a global scourge. In fact, a significant
reduction in iodine deficiency by securing iodization of salt
and a major decrease in the prevalence of clinical forms of
vitamin A deficiency have been achieved as part of the efforts
of the last two decades. Similarly, virtually everywhere except
in sub-Saharan Africa, the prevalence of underweight and
stunting of children less than five years of age has significantly
declined. Despite this degree of progress, the absolute number
of malnourished children continues to increase.
Policies and programmes to achieve success vary between
countries; there is no single formula or combination of inter-
ventions that will work in every case. The social and economic
costs of malnutrition for developing and transitional areas of
the world are enormous. Investing in nutrition is well justified,
not only because of the reduction in health-care expenditures,
but also because of the improvement of productivity, enhanced
cognitive performance and educational achievements, and their
corresponding impacts on economic and social development.
Moreover, as singled out by the UN Standing Committee on
Nutrition Commission on Nutrition Challenges:
‘To live a life without malnutrition is a fundamental
human right. The persistence of malnutrition,
especially among children and mothers, in this
world of plenty is immoral. Nutrition improvement
anywhere in the world is not a charity but a
societal, household and individual right. It is the
world community’s responsibility to find effective
ways and means to invest for better livelihood and
to avoid future unnecessary social and economic
burdens. With collective efforts at international,
national and community levels, ending malnutrition
is both a credible and achievable goal.’
James et al. 2000
The human rights dimension of hunger and malnutrition is
the ultimate goal. We need not justify the cause by the
damage avoided or the loss of potential economic and
social gains, but should reinforce our argument by the need
to respect, protect and promote the right to safe and nutritious
food. More recently, the definition of Millennium Develop-
ment Goals, to be achieved by 2015, have served to invigo-
rate the UN system’s global development agenda. The
Millennium Development Goals highlight the pending
agenda in terms of minimal standards for progress in global
health, nutrition and development.
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The UN Standing Committee on Nutrition Commission on
Nutrition Challenges (James et al. 2000) identified the follow-
ing sixteen major inter-linked nutrition challenges. The first
eight are part of the pending agenda, the remainder are emer-
ging problems that will dominate the global agenda in the
years ahead:
1. Some 30 million infants are born each year in developing
countries with intra-uterine growth retardation, represent-
ing approximately 24% of all newborns in these
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countries. Population-wide interventions aimed at pre-
venting fetal growth restriction and low birth weight are
urgently needed.
2. There are still more than 150 million underweight pre-
school children worldwide, and close to 200 million
stunted children. This underweight and stunting is the
tip of the iceberg. Suboptimal growth may affect many
more. Stunting is linked to mental impairment. At current
rates of improvement, by the year 2020, approximately
one billion children will be growing up stunted in their
physical growth and impaired in their mental
development.
3. High proportions of Asian and African mothers are
undernourished: this is exacerbated by seasonal food
shortages, especially in Africa. Approximately 243
million adults in developing countries are severely under-
nourished, judged by a BMI of less than 17 kg/m2, with
greater numbers with modest underweight having an
impaired work capacity and a lower resistance to
infection.
4. Anaemia during infancy, made worse by maternal under-
nutrition, causes poor brain development. Anaemia is also
extremely prevalent in school children and adolescents.
Maternal anaemia is pandemic, over 80% in some
countries, and is associated with very high rates of
maternal death.
5. Severe vitamin A deficiency is on the decline in all
regions. However, sub-clinical vitamin A deficiency still
affects between 140 and 250 million preschool children
in developing countries, and is associated with high
rates of morbidity and mortality. These numbers do not
take into account vitamin A deficiency in older children
and adults and thus seriously underestimate the total
burden of vitamin A deficiency.
6. Evidence from both developing and industrialized
countries suggests a fundamental link between maternal
and early childhood undernutrition and an increased sus-
ceptibility in adult life to non-communicable diseases
(NCD) such as diabetes, heart disease and hypertension.
These diet-related diseases–including some forms of
cancer–are already of public health significance in devel-
oping countries.
7. Overweight and obesity are rapidly increasing in all
regions, affecting children and adults alike. There are
approximately 250 million obese adults already and
these problems are now so common in developing
countries that they are dominating more traditional
public health concerns such as undernutrition and infec-
tious disease. Obesity, especially abdominal obesity pro-
moted by early fetal and childhood undernutrition, is a
major risk factor for a number of NCD, adult-onset dia-
betes and hypertension in particular.
8. Efforts are needed to sustain the remarkable progress
made in the last decade towards universal salt iodization
and the elimination of iodine deficiency disorders.
Monitoring systems, quality control and sound legislation
are key priorities, as well as improving outreach to iso-
lated communities.
9. There has been an alarming rise in the number of emer-
gency nutrition problems over the last 10 years. The
numbers of refugees and internally displaced persons
peaked during the crisis in the African Great Lakes
Region in 1995 when there were over 18 million in
sub-Saharan Africa alone. Experience has shown that
when food aid deliveries are uninterrupted and humani-
tarian organizations have constant access to the dis-
placed population, undernutrition rates can be kept to a
minimum.
10. Physical activity is usually considered separately from
nutrition, but the nutrition community now needs to
have professional involvement with this issue. In the
developing world, especially in rural areas, adults are
engaged in high levels of physical activity which require
a high level of energy intake. The ability to sustain physi-
cal work is impaired when adults are underweight. More-
over, underweight subjects are frequently sick,
particularly from infectious diseases such as diarrhoea
and respiratory infections.
11. By the end of 1998, there were approximately 32 million
adults and 1·2 million children living with HIV/AIDS. In
total, 3 million children under 15 years of age worldwide
have contracted HIV since the beginning of the pan-
demic, 90% of whom were born in Africa. In parts of
sub-Saharan Africa, HIV/AIDS is wiping out an entire
generation of the most economically active people.
There is evidence that transmission rates and the pro-
gression of the disease are higher in undernourished
populations.
12. Zinc deficiency has recently been brought to the attention
of the international community. Mild to moderate zinc
deficit may be an important cause of childhood stunting.
Zinc deficiency is thought to be common in children and
during pregnancy throughout the developing world. Zinc
may also have an important role to play in programmes
designed to address common life-threatening childhood
illnesses, such as lower respiratory tract infection and
diarrhoea.
13. Changing food consumption patterns. Food production,
processing and manufacturing have responded to man-
kind’s inherent demand for sugary, salty and fatty foods.
The culinary and industrial enhancement of the energy den-
sity of foods by adding fats and sugars is invaluable in times
of need, but potentially disadvantageous in times of plenty,
especially if sedentary life-styles predominate. As societies
become more urban, life-styles tend to become less active
andmore sedentary. This set of changes, known as the nutri-
tion transition, is a major challenge facing the world in
future decades.
14. The need for enhancing food quality more than food
quantity. Development plans have concentrated on
increasing cereal production, but horticulture should be
promoted to aid the increased vegetable and fruit con-
sumption needed to prevent childhood blindness and
limit the development of cataracts, some adult cancers
and CVD. A major increase in fish and lean meat con-
sumption in some communities, particularly in South
Asia, would help prevent anaemia, promote childhood
growth, enhance resistance to infection and improve
maternal and fetal health. A transformation in the pro-
motion and processing of fats to limit the rise in total
fat consumption to perhaps only 20% of dietary energy
in sedentary adult populations would also improve
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health. There is a clear need for a new approach to health
and food policies in most parts of the world. Strategies
for improving access and availability of healthy diets at
affordable prices for all communities should be a key
part of these policies.
15. Developing countries are now having to deal with a
double burden of infectious disease, childhood mortality
and undernutrition alongside diet-related NCD. As well
as the obvious health effects, this double burden has
very serious economic and social implications for these
countries. Treatment of NCD is costly compared with
public health preventive strategies. Favouring treatment
rather than prevention is a mistake already made in the
industrialized world. In affluent Western societies
increasing income inequality is linked to increasing
health disparities between the rich and poor, despite sus-
tained economic development.
16. Promoting healthy ageing must become a major policy
initiative globally. Body composition changes with age,
and the decline in lean body mass leads to decreased
strength and mobility, poor balance and an increased fre-
quency of falls. Conserving muscle mass in old age is
therefore a strategy for preserving strength, and is also
of significance in maintaining physical activity, retarding
insulin resistance and ensuring normal immune function.
Preventing age-related decline in cognitive function and
maintaining good eye health into older age are also
both major challenges.
We have chosen to focus the final section of the present
paper on the last of these challenges, namely finding nutri-
tional means to ensure healthy ageing. This is a challenge
facing developed and developing countries alike, which
requires appropriate integration of available basic biological
knowledge for the formulation and evaluation of nutrition
interventions. Our short review will focus specifically on
nutrition as a means to prevent or delay cognitive decline.
Nutrition and healthy ageing
Developing country populations are currently undergoing
rapid and unprecedented changes in their age structure, result-
ing in considerable population ageing. While the percentage of
the total population under 15 years of age will drop from its
current level of 33 to 22% in 2050, the percentage aged
over 60 years will more than double from 8 to 19% over
the same time. The increase in the proportion of over 60s in
developing countries is 1·5 times faster than that projected
in developed countries, and by 2050, 80% of all over 60s
will be living in developing countries (United Nations, 2001).
The importance of good nutrition among older people for
the maintenance of health has long been advocated, and
evidence-based dietary recommendations for older people
have recently been published (World Health Organization/
Tufts University, 2002). However, for a variety of functional,
physiological, psychological and social reasons older people
are nutritionally vulnerable and frequently consume diets
that are poor in both quality and quantity. This vulnerability
often results in macronutrient and micronutrient undernutrition
among older people in both developed and developing
countries.
As populations age, the proportion and absolute number of
individuals with age-related cognitive impairment rises
(Melzer et al. 1997). There has been particular interest in the
hypothesis that improving the diet of older people may be able
to delay the initiation, or slow the progression, of cognitive
decline. Research in this area, initially aroused by a small
survey demonstrating an association between blood levels of
vitamins C and B12 and tests of cognitive ability (Goodwin
et al. 1983), remains very active (Manders et al. 2004). The evi-
dence fromcross-sectional studies is indeed quite suggestive of a
link between B vitamin (Selhub et al. 2000) and antioxidant
(Haller et al. 1996; Jama et al. 1996; Perrig et al. 1997; Perkins
et al. 1999) status and cognitive function in older people.
Cross-sectional surveys on this topic are common, but very
few studies have looked at the longitudinal association
between micronutrient status and cognitive health. Of particu-
lar note here is a recent 3-year cohort study among 2889 com-
munity-dwelling adults aged 65 years and above which
showed that individuals in the highest quintile of total vitamin
E intake had a 36% lower rate of cognitive decline over three
years than those in the lowest vitamin E quintile (Morris et al.
2002). While this is potentially a very important finding,
significant concerns have recently been raised that high-dose
vitamin E supplementation may increase the severity of cer-
tain morbidities (Graat et al. 2002) and the risk of all-cause
mortality (Miller et al. 2005).
Unfortunately, positive findings of associations between
micronutrient status and cognitive health have not been corro-
borated by the results of the few clinical trials of micronutrient
supplementation. Indeed, a series of Cochrane reviews has
concluded that there is no evidence of an effect of thiamin
(Rodriguez-Martin et al. 2001), B6 (Malouf & Grimley,
2003), folate (Malouf et al. 2003), B12 (Malouf & Areosa
Sastre, 2003) or vitamin E (Tabet et al. 2000) supplementation
on cognitive health. Various reasons behind the contradictory
findings between observational and interventional studies have
recently been discussed (Dangour et al. 2004; Lawlor et al.
2004). These include uncontrolled confounding in observa-
tional studies, small interventions of short duration, and the
unrepresentativeness of the dietary supplements used.
Increasing awareness of genetic polymorphisms, as well as
the interactions between genes and nutrients, has highlighted a
further complication in such studies. For example, a recent
meta-analysis reviewing the association between plasma
homocysteine levels and CVD (Wald et al. 2002) focused
on the additional risk to individuals with a mutation in a
gene coding for an enzyme involved in folate metabolism.
The mutation results in a 20% elevation in plasma homocys-
teine levels and a concomitantly higher risk of both IHD and
deep vein thrombosis. In individuals with this mutation, folate
intake must clearly be higher than normal to attain a lower risk
profile.
In contrast to B vitamins and antioxidants, far less attention
has been paid to other dietary factors plausibly related to cog-
nitive health in older age, such as n-3 long-chain PUFA (n-3
LCP). The brain is particularly rich in n-3 LCP such as EPA
and DHA, and n-3 LCP have repeatedly been shown to be cru-
cial to brain development in man (Uauy et al. 2001). Animal
studies have demonstrated that ageing is associated with
decreased levels of DHA in rat brains (Suzuki et al. 1989;
Favrelere et al. 2000). Moreover, cognitive testing on rats
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fed on a low-DHA diet for one or more generations has
demonstrated clear deficits in cognitive function in DHA-
deficient rats (Suzuki et al. 1998; Lim & Suzuki, 2000; Cata-
lan et al. 2002). This decrease with ageing in n-3 LCP level in
total brain lipids has also been reported in man, and it has been
postulated that this decline is correlated in part with age-
related deterioration of functions of the central nervous
system (Soderberg et al. 1990, 1991).
Evidence supporting the potential importance of increased
fish and n-3 LCP consumption for good cognitive health in
older age is beginning to emerge. For example, a recent
cross-sectional survey has reported that higher fatty fish and
n-3 LCP consumption is associated with a reduced risk of
impaired cognitive function (Kalmijn et al. 2004). Similarly,
prospective studies have demonstrated that increased fish con-
sumption is associated with a decreased risk of dementia
(Kalmijn et al. 1997; Barberger-Gateau et al. 2002) and
Alzheimer’s disease (Morris et al. 2003) among older people.
A clue to the role of n-3 LCP in preventing cognitive decline
or dementia is provided by analysis of erythrocyte membrane
composition among older people taking part in the Etude du
Vieillissement Arte´rial (EVA) study (Heude et al. 2003). The
study demonstrated that individuals who declined cognitively
over a 4-year follow-up had a higher proportion of stearic acid
in their erythrocyte membranes than those who showed no
decline. Importantly, erythrocyte membrane content of total
n-3 PUFA, and specifically DHA, was inversely associated
with cognitive decline (Heude et al. 2003).
The mechanisms behind the role of n-3 LCP in improving
vascular health outcome are beginning to be relatively well
understood, and include the ability of n-3 LCP to inhibit hepa-
tic triacylglycerol synthesis and, by modifying eicosanoid
function, to cause vascular relaxation, a diminished inflamma-
tory process and decreased platelet aggregation (Uauy &
Valenzuela, 2000). These actions may be extremely important
in decreasing the risk of silent brain infarcts that are a cause of
vascular cognitive impairment (O’Brien et al. 2003) and have
been shown to be directly associated with cognitive decline
(Vermeer et al. 2003).
Some very exciting recent work has focused on the protec-
tive role of DHA in the brain. In a mouse model of ischaemic
stroke, two of the major causes of post-stroke neuronal injury,
namely lipid peroxidation and leucocyte infiltration, appear to
be inhibited by a bioactive docosanoid derived from DHA
(Marcheselli et al. 2003). This docosanoid, 10-17S-docosa-
triene, more recently named neuroprotectin D1 (Mukherjee
et al. 2004), has been shown to act potently on cultured neur-
onal cells to down-regulate proinflammatory gene expression
(Marcheselli et al. 2003). The role of DHA in modifying
gene expression was also demonstrated in a study on human
fetal retinal explants, in which the presence of DHA in the
growth serum was found to increase the expression of 14%
of genes, while oleic acid increased gene expression by less
than 0·5% (Rojas et al. 2003).
Moreover, DHA is known to protect in vitro cultured hippo-
campal neurons from apoptotic death (Kim et al. 2000). This
latter action has been replicated among retinal pigment
epithelium and has been directly linked to the effects of
neuroprotectin D1 to counteract oxidative-stress triggered
DNA damage, as well as up-regulate antiapoptotic, and
decrease proapoptotic, protein expression (Mukherjee et al.
2004). In a mouse model of Alzheimer’s disease (Tg2576), diet-
ary DHA deficiency was shown to induce a decline in DHA
content of the frontal cortex. This was associated with an
increase in the fractin:actin ratio, and the accumulation of the
fragmented actin (fractin) was associated with a decrease in
the content of key proteins responsible for post-synaptic proces-
sing such as drebin and synapsin. Fractin accumulation corre-
lated with a significant loss of dendritic spine formation, loss
of the p85a subunit of phosphatidylinositol kinase and
increased oxidative damage as evidenced by increased carbonyl
production. No neuronal losses were observed in the hippo-
campus. These structural and biochemical alterations are simi-
lar to those found in the brain of early Alzheimer’s disease
sufferers. Behavioural alterations, in terms of poorer short-
term memory and learning capacity, were established in the
DHA-deficient animals. Supplementation of these adult mice
with DHA modified brain fatty acid composition, protected
them in part from the adverse biochemical effects, and resulted
in improved cognitive performance (Calon et al. 2004).
Conclusions
Nutrition plays an important role in defining health and well-
being at all stages of the life course. In past decades, nutrition
was centred on optimizing growth, and preventing infectious
disease morbidity, death and disability, in early life. These
efforts are responsible for an increase in child survival and a
corresponding increase in mean life expectancy of those
born in developed and transitional countries. Much still
needs to be done to address malnutrition and associated
child deaths in sub-Saharan Africa and South Asia. Presently,
new initiatives are being launched to prevent premature adult
deaths globally. WHO, in collaboration with FAO and the UN
system, has launched a global strategy based on diet, nutrition
and physical activity to prevent nutrition-related chronic dis-
eases (obesity, diabetes, myocardial infarct, stroke, hyperten-
sion, and some forms of cancer). If effective, this should
lead to further improvements in adult life expectancy and to
increasing numbers of people reaching older ages.
The time has come to define preventative strategies not
only to avoid premature deaths, but also to preserve function
in older people. This has direct implications on quality of life
and on health expenditures destined for this age group.
Adding healthy life years at moderate costs associated to pre-
ventive measures including dietary interventions makes more
sense than increasing expenditures in intensive care in the
last days of life. The challenge for nutrition scientists is
now to integrate existing knowledge and further advance
research on how to prevent age-related declines in neural
function and vascular health, which is essential for preserving
function in older age. These are by no means obligatory con-
ditions associated to ageing; we know that micronutrient suf-
ficiency and quality of the fat supply play key roles in
preserving function. Age-related cognitive decline is by
now amongst the main causes of lost disability-adjusted life
years in people older than 60 years of age. An effectiveness
study on DHA and EPA for the prevention of cognitive
decline (the OPAL study) and a cost-effectiveness study on
the role of nutrition and physical activity in preserving
strength and host defences in older people (the CENEX-
Chile study), are currently being conducted by the authors.
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Until we find cost-effective interventions to prevent cognitive
decline in older people, we will continue to pay the human
and social cost of our insufficient action.
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